Schedule 13D ownership disclosure

LOXO ONCOLOGY INC

Security class unavailable · CUSIP: 548862101

Event date: 2017-11-16

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
Unavailable
Percent of class
4.8700%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0000947871-17-000952
Form type
SC 13D/A
Filer
Loxo Oncology, Inc.
CIK
CIK 1581720
Filed
Nov 20, 2017
Reporting period
Nov 16, 2017
Description
Schedule 13D beneficial ownership

Explore SEC Filings Hub